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Abstract
Introduction:  Although  smoking  is  the  main  risk  factor,  it  is  not  the  only  one.  Current  medical
evidence  shows  that  airﬂow  limitation  also  develops  for  other  reasons.
Objective:  Our  main  objective  was  to  determine  risk  factors  which  are  associated  with  chronic
pulmonary  disease,  among  patients  of  40--85  years  old  at  Internal  Medicine  and  Pneumology
Departments  at  the  Jose  Carrasco  Arteaga  and  Vicente  Corral  Moscoso  Hospitals.
Materials  and  methods:  This  is  a  case--control  study.  Our  sample  was  calculated  with  a  95%
conﬁdence  interval,  an  80%  ratio  of  statistical  power,  an  odds  ratio  of  3  and  a  10%  exposure
factor with  its  lowest  frequency;  a  pairing  procedure  was  applied  according  to  gender  and  age
and subjects  entered  the  study  sequentially.
Results:  In  all,  318  patients  were  evaluated,  106  of  whom  were  cases  and  212  controls.  Both
groups were  similar  in  age  and  the  same  gender  (P  >  .05).  Males  constituted  72.3%,  with  an
average age  of  62.4  years  (±13.1D.E.).  An  index  of  over  20  pack  years  was  a  risk  factor  for  COPD
(OR: 9.03,  95%  CI:  3.76--21.72;  P  =  .000).  In  the  case  of  biomass  fumes,  this  was  an  exposure
index of  over  100  h/year  (OR:  9.65,  95%  CI:  4.87--19.32,  P  =  .000).  Dust  exposure,  air  pollution
and a  family  history  of  COPD  in  patients’  parents  were  not  risk  factors  for  COPD.
Conclusions:  Risk  factors  for  COPD  were  attributable  to  smoking  and  biomass  smoke  exposure.
© 2015  Sociedad  Médica  del  Hospital  General  de  México.  Published  by  Masson  Doyma  México
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PALABRAS  CLAVE
Enfermedad  pulmonar
obstructiva  crónica;
Tabaquismo;
Humo  de  len˜a
Factores  de  riesgo  para  enfermedad  pulmonar  obstructiva  crónica.  Resultados  del
estudio  FARIECE
Resumen
Introducción:  El  tabaquismo  es  el  principal  factor  de  riesgo  para  enfermedad  pulmonar  obstruc-
tiva crónica  (EPOC),  pero  no  es  el  único.  La  evidencia  médica  actual  demuestra  que  la  limitación
al ﬂujo  aéreo  también  se  desarrolla  por  otras  causas.
Objetivos:  Describir  el  perﬁl  demográﬁco  de  los  pacientes  con  EPOC  e  identiﬁcar  posibles  fac-
tores de  riesgo  para  su  desarrollo  en  sujetos  entre  40  y  85  an˜os  en  los  servicios  de  neumología  y
medicina interna  de  los  Hospitales  José  Carrasco  Arteaga  y  Vicente  Corral  Moscoso  en  la  ciudad
de Cuenca,  Ecuador.
Métodos:  Estudio  multicéntrico  de  casos  y  controles.  Se  reclutó  como  casos  a  personas  entre  40
y 85  an˜os  con  diagnóstico  de  EPOC  y  como  controles  a  personas  de  la  misma  edad  sin  diagnóstico
previo de  EPOC  y  que  no  presentaban  síntomas  de  EPOC  en  el  momento  de  realizar  el  estudio.
La muestra  se  calculó  sobre  la  base  del  95%  de  nivel  de  conﬁanza,  80%  de  poder  estadístico,
OR de  3  y  10%  del  factor  de  exposición  con  más  baja  frecuencia;  se  pareó  por  edad  y  sexo  e
ingresaron  al  estudio  de  manera  secuencial.
Resultados:  Se  evaluaron  318  sujetos,  106  casos  y  212  controles.  Los  grupos  fueron  similares
en promedio  de  edad  y  sexo  (p>  0.05).  El  72.3%  fueron  hombres;  el  promedio  de  edad  fue  62.4
an˜os (±13.1D.E.).  El  índice  paquetes/an˜os  superior  a  20  resultó  ser  factor  de  riesgo  para  EPOC
(OR de  9.03,  IC95%,  3.76  --  21.72;  valour  de  p  =  0.000),  al  igual  que  la  exposición  al  humo  de
len˜a en  horas/an˜os  mayor  a  100  (OR  de  9.65,  IC  95%  4.87  --  19.32;  valour  de  p  =  0.000).
Conclusiones:  Los  factores  de  riesgo  para  EPOC  son  exposición  al  tabaco  y  humo  de  len˜a.
© 2015  Sociedad  Médica  del  Hospital  General  de  México.  Publicado  por  Masson  Doyma  México
S.A. Todos  los  derechos  reservados.
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eIntroduction
Chronic  obstructive  pulmonary  disease  (COPD)  is  a  world-
wide  public  health  problem.1 The  Global  Initiative  for
Chronic  Obstructive  Lung  Disease  (GOLD)  deﬁnes  COPD  as
a  common,  preventable  and  treatable  disease  characterised
by  progressive  airﬂow  limitation.2 The  prevalence  of  COPD  in
those  aged  between  40  and  80  years  in  Spain  varies  between
9.1%,  according  to  the  IBERPOC3 study,  and  10.2%  according
to  the  EPI-SCAN  study  (95%  CI:  9.2--11.1).4
Worldwide,  this  disease  is  the  fourth  cause  of  mortality
and  its  prognosis  is  linked  to  multiple  factors  related  to  the
severity  of  the  disease.5 The  PREPOCOL  study  shows  that  the
prevalence  of  COPD  is  8.9%  in  over-40-year-olds.6 In  the  WHO
2014  records,  there  are  65  million  COPD  patients  globally
and  it  is  estimated  that  by  2030  the  disease  will  have  been
become  the  third  leading  cause  of  death  and  the  fourth  for
disability  worldwide.7
The  PLATINUM  study  concludes  that  in  Latin  America  the
lowest  prevalence  of  COPD  is  7.8%,  in  Mexico,  and  19.8%,  the
highest,  in  Uruguay.  The  rate  is  higher  in  men  than  in  women,
passive  smokers,  and  those  exposed  to  woodsmoke  and
dust.8 Smoking  is  the  main  risk  factor  and  the  most  studied.9
It  is  of  great  concern  that  more  and  more  non-smokers
are  developing  the  disease,  and  this  has  been  the  start-
ing  point  for  new  research  on  other  associated  factors.10
There  is  overwhelming  statistical  evidence  to  suggest  that
this  is  not  the  only  one.10 When  considering  the  possibility
of  extending  these  categories  in  order  to  catalogue  asso-
ciated  factors,  this  condition  will  affect  more  those  over
40,  thus  becoming  a  major  public  health  problem.11 The
o
i
american  Lung  Association  cites  exposure  to  dust,  environ-
ental  pollution  and  inherited  genetic  disorders  such  as
omozygous  deﬁcit  of  alpha-1-antitrypsin,  as  risk  factors  for
OPD.12
Hu  et  al.  mention  that  over  the  past  decade,  COPD  has
ecome  a  worldwide  public  health  problem,  and  also  noted
s  a  risk  factor  exposure  to  smoke  from  burning  biomass
ﬁrewood),  especially  in  unventilated,  conﬁned  interiors.13
he  Bolivian  Institute  of  Altitude  Biology  in  the  Faculty  of
edicine  at  the  Universidad  Mayor  de  San  Andres  in  Bolivia
oncluded  that  in  la  Paz,  the  prevalence  of  COPD  is  12.9%,
nd  noted  that  there  are  other  factors  apart  from  smoking
hat  cause  disease,  such  as  the  use  of  ﬁrewood,  environ-
ental  pollution  and  workplace  exposure:  data  that  should
e  considered  when  further  research  is  undertaken.14 The
se  of  ﬁrewood  for  cooking  and  heating  homes  is  common  in
eveloping  countries.15
The  association  between  COPD  and  woodsmoke  has  been
emonstrated  in  several  epidemiological  studies,  some  of
hich  were  conducted  in  Latin  America  by  Dennis  et  al.,16
nd  Pérez-Padilla  et  al.17 in  Mexico;  Luna  in  Guatemala,18
nd  Albalak  in  Bolivia.19 Most  studies  associate  this  with
hronic  respiratory  symptoms.  Dennis  and  Pérez  Padilla
ink  exposure  time  with  spirometry  studies  and  describe
 direct  relation  between  frequency  of  COPD,  respiratory
ymptoms  and  increased  exposure  to  woodsmoke.16,17 A  big
uestion  remains  as  to  whether  woodsmoke,  the  working
nvironment,  hereditary  genetic  factors  and  pollutants  in
ur  environment  could  be  risk  factors.  The  aim  of  this  paper
s  to  describe  the  demographic  proﬁle  of  patients  with  COPD
nd  identify  possible  risk  factors  for  the  development  of  the
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isease  in  individuals  between  40  and  85  years  attending  two
eneral  hospitals  in  Cuenca,  Ecuador.
aterials and methods
tudy  design
o  undertake  the  FARIECE  study  (risk  factors  of  chronic
bstructive  pulmonary  disease  in  the  city  of  Cuenca,
cuador),  a  multicentre,  case--control  study  was  designed
nd  implemented  between  January  2011  and  December  2012
t  the  Pneumology  and  Internal  Medicine  Departments  (inpa-
ient  and  outpatient)  at  the  Carrasco  Arteaga  and  José
icente  Corral  Moscoso  Hospitals,  in  the  city  of  Cuenca,
cuador.  The  protocol  was  reviewed  and  approved  by  the
esearch  and  Bioethics  Committees  at  the  University  of
uenca  Medical  School  at  the  José  Carrasco  Arteaga  Hospital
nd  Vicente  Corral  Moscoso  Hospital  in  Ecuador.
opulation  and  ﬁeld  of  study
o  recruit  patients,  doctors  specialising  in  pneumology  and
nternal  medicine  at  the  two  hospitals  were  involved.  The
iagnosis  of  COPD  was  based  on  GOLD  guidelines,  supported
y  clinical  history  and  lung  function  tests  that  demonstrated
irﬂow  limitation  (ratio  of  FEV1/FVC  <  .70  pre-  and  post-
ronchodilator),  and  the  fact  that  this  limitation  was  not
eversible  after  bronchodilation  testing  (FEV1  <  80%  of  the
redicted  value  and  a  FEV1/FVC  <  70%  after  using  salbuta-
ol,  with  no  reversibility).  Cases  selected  were  subjects
ith  a  clinical  and  spirometry  diagnosis  of  COPD,  between
0  and  85  years  old,  who  were  attending  inpatient  and/or
utpatient  units.  As  controls,  subjects  between  40  and  85
ears  with  no  diagnosis  of  COPD  and  normal  spirometry
ere  selected.  These  subjects  were  inpatients  and/or  out-
atients.  The  controls  had  to  be  included  in  the  ﬁrst  7  days
fter  identiﬁcation  of  each  case,  and  they  could  have  no
amily  relationship  between  each  other.
Patients  excluded  were  those  with  community-acquired
neumonia,  congestive  heart  failure,  chronic  or  pulmonale,
osocomial  pneumonia  or  ventilator-caused,  tuberculosis,
nterstitial  lung  disease,  pulmonary  ﬁbrosis,  asthma,  spirom-
try  consistent  with  an  obstructive  pattern  with  reversibility
f  over  12%,  or  200  ml,  after  salbutamol;  restrictive  or  mixed
pirometry  pattern;  or  exacerbation  in  their  lung  disease
ver  the  previous  4  weeks.  Also  excluded  were  patients
ith  any  physical  or  mental  impairment  that  would  hinder
unning  diagnostic  tests,  and  people  who  had  not  signed
nformed  consent  to  participate  in  the  study.
The  sample  was  calculated  using  multiple,  stratiﬁed
robability  sampling  without  replacement,  based  on  a  95%
onﬁdence  interval;  80%  statistical  power;  OR  3;  and  10%
f  the  lowest  rate  of  exposure  factor.  Subjects  were  paired
y  age  and  sex  and  entered  the  study  sequentially.  In  the
rst  phase  we  worked  with  medical  specialists  in  Pneumol-
gy  and  Internal  Medicine  at  the  two  hospitals.  Taking  part
ere  two  pneumologists  and  3  internists  from  each  hospi-
al,  i.e.  2  teams  of  5  specialists  who  each  contributed  159
ubjects,  53  cases  and  106  controls.
In  the  second  phase,  a  specialist  at  each  centre  was
elected  from  among  professionals  with  experience  in  both
S
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linical  and  epidemiological  research  to  coordinate  their
roup.  The  third  phase  consisted  of  patient  selection.  These
ere  selected  by  systematic  sampling,  obtained  from  the
aily  list  of  hospitalised  patients  and  from  patients  with  an
ppointment  with  a specialist  who  was  taking  part  in  the
tudy.  These  patients  had  to  meet  all  the  inclusion  criteria
nd  none  of  the  previously  mentioned  exclusion  criteria.  In
rder  to  have  2  controls  per  case,  315  patients  had  to  be
valuated.
uestionnaires  on  data  collection
ach  specialist  participant  ﬁlled  in  a  questionnaire  on
atient  data  collection.  This  had  to  be  completed  at  one
ingle  medical  visit  and  included  socio-demographic  data  on
moking  habits,  personal  and  family  history,  comorbidities,
reatment,  spirometry  data,  diagnosis  and  probable  known
isk  factors.  The  data  on  personal  and  family  history  and
omorbidity  were  reported  by  patients  and/or  taken  from
edical  records.  We  deﬁned  the  variables  studied  on  the
asis  of  the  PLATINO21 study:  current  smoking  was  deﬁned
s  any  number  of  cigarettes  smoked  in  the  previous  30  days;
he  number  of  cigarettes  smoked  currently;  and  the  num-
er  of  cigarettes  smoked  per  day  currently;  the  number  of
igarettes  smoked  over  the  subject’s  lifetime;  and  the  total
umber  of  cigarettes  smoked,  on  average,  per  day,  over  the
ntire  period  during  which  the  subject  had  smoked  in  his/her
ife.  Subjects  who  had  smoked  less  than  one  cigarette  per
ay  in  one  year  were  considered  non-smokers.  Also  included
as:  the  age  at  which  subjects  had  stopped  smoking,  and  the
ge  at  which  they  had  given  up  smoking  completely.
The  rate  of  smoking  exposure  was  classiﬁed  into  two
roups.  The  ﬁrst  group  was  designated  low  risk.  The  ﬁrst
wo  categories  of  risk  classiﬁcation  proposed  by  Villalba  and
ols22 were  used  (no  risk  and  average  risk).  The  second  group
as  designated  as  a  high-risk  group,  taking  the  last  two  cat-
gories  of  this  classiﬁcation  (acute  risk  and  high  risk)  and
ncluding  exposure  to  woodsmoke  as  background  for  the  use
f  ﬁrewood  in  the  kitchen  stove  or  for  home  heating.  Other
onsiderations  were  level  of  education,  taken  as  the  last
ourse  completed  at  school;  exposure  to  dust  in  the  work-
lace;  duration  of  exposure  to  dust;  and  the  rate  of  exposure
o  smoke  for  subjects  exposed  to  more  than  200  h/year
result  of  multiplying  the  number  of  hours  exposed  daily
y  the  years  of  exposure  to  woodsmoke).  The  risk  of  COPD
as  found  to  be  75  times  higher  than  in  people  without  this
xposure.17
ulmonary  function  tests
ll  cases  and  controls  underwent  base  line  and  post  bron-
hodilator  spirometry  tests.  The  recommendations  of  the
uropean  Respiratory  Society  and  the  American  Thoracic
ociety20 were  followed  to  ensure  reproducibility  of  the  data
btained.tatistical  analysis
he  population  taken  for  statistical  analysis  included  all
elected  patients  who  met  the  inclusion  criteria  and  none
Risk  factors  for  chronic  obstructive  pulmonary  disease  165
Table  1  General  characteristics  of  the  study  group.
Variables  Cases
n  =  106
Number  --  percentage
Controls
n  =  212
Number  --  percentage
Value  P
Age  (X  ±  D.E.)  62.5  ±  13.1  62.4  ±  13.1  .928
Age groups
40--50  years  28  (26.4)  57  (26.9)
.99651--60 years  19  (17.9)  38  (17.9)
61--85 years  59  (55.7)  117  (55.2)
Sex
Female  33  (31.1) 55  (25.9)
.330Male 73  (68.9) 157  (74.1)
Marital  status
Single  14  (13.2)  46  (21.7)
.237
Married  70  (66.0)  130  (61.3)
Partnered  3  (2.8)  5  (2.4)
Widow/er  13  (12.3)  15  (7.1)
Divorced  6  (5.7)  16  (7.5)
Education
≤6 years 57(53.8) 41  (19.3)
.0007--12 years 33  (31.1) 77  (36.3)
≥13 years 16  (15.1) 94  (44.3)
Occupation
Mental  34  (32.1)  83  (39.2)
.217Physical  effort  72  (67.9)  129  (60.8)
Residence
Urban 80  (75.5)  186  (87.7)
.005Rural 26  (24.5)  26  (12.3)
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oSource:  Data sheets -- produced by the author.
of  the  exclusion  criteria.  Descriptive  statistics  of  all  param-
eters  were  produced,  including  measurement  of  central
tendency  and  dispersion  with  its  two  tailed  conﬁdence  inter-
val  of  95%  for  quantitative  variables,  and  absolute  and
relative  frequencies  for  qualitative  variables.  Pairing  was  by
age  and  sex.  In  the  comparison  of  independentw  variables
(cases  versus  controls)  and  odds  ratio,  conﬁdence  interval
of  95%  was  obtained.  Statistical  signiﬁcance  was  calculated
from  the  P  value.  The  Student  t  test  was  used  in  the  case  of
quantitative  variables.  The  SPSS  statistical  package,  version
20,  was  used  for  all  statistical  analyses.
Results
A  total  of  10  researchers  recruited  318  patients,  106  cases
and  212  controls.  Patient  characteristics  are  shown  in
Table  1.  The  average  age  in  the  case  group  was  62.5  years
of  age,  with  standard  deviation  (SD)  ±  13.1;  and  in  the  con-
trol  group:  62.4  years  of  age  with  standard  deviation  (SD)
of  ±13.1.  Average  age  in  the  case  group  and  controls  was
similar  (P-value  .928).  A  total  of  88  women  (27.7%)  and  230
men  (72.3%)  were  located,  of  whom  73  were  male  cases
(68.9%)  plus  157  male  controls  which  constituted  74.1%  of
the  total.  Contrasting  these  proportions  with  the  Chi-square
test  gave  a  P-value  of  .330,  thus  conﬁrming  that  the  groups
3
t
P
Iboth  cases  and  controls)  were  similar  for  the  gender  vari-
ble.  The  lower  limit  for  age  was  40  and  the  upper  limit  was
5;  the  median  was  63  years;  the  25th  percentile  was  50  and
he  75th  percentile  was  74.
For  their  analysis,  they  were  classiﬁed  into  three  age
roups  (40--50  years;  51--60  years;  and  61--85  years  of  age).
he  highest  percentages  were  for  patients  aged  over  or
qual  to  61  years:  59  cases  (55.7%).  Among  the  group  aged
0--50  years  old,  28  cases  were  identiﬁed  (26.4%)  and  among
hose  aged  51--60  years  old,  19  cases  (17.9%)  were  identi-
ed.  The  predominant  marital  status  in  the  case  group  was
arried:  70  patients  (66%),  followed  by  single:  14  patients
13.2%).  Of  the  318  patients,  110  patients  (34.6%)  were  stud-
ed  over  a period  of  7--12  years  and  110  patients  (34.6%)  were
tudied  for  13  years  or  longer.  Most  cases  had  no  education
hatsoever  or  had  only  completed  primary  education.  Out
f  all  the  cases  we  found  a  total  of  72  patients  whose  occu-
ation  required  physical  effort,  i.e.  67.9%  or  34  patients.
hose  with  a  mental  occupation  represented  32.1%.
By  correlating  the  P-value,  odds  ratios  and  CI  of  95%  for
he  groups  analysed  it  was  found  that  a  pack-year  index  of
ver  20  proved  to  be  a  risk  factor  for  COPD  (OR:  9.03,  95%  CI:
.76--21.72  and  P-value  of  .000).  For  exposure  to  woodsmoke
his  ratio  was  h/year  over  100  (OR:  9.65,  95%  CI:  4.87--19.32;
-value  of  .000).  Full  patient  details  are  shown  in  Table  2.
n  the  case  group  with  a  total  of  106  patients  with  chronic
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Table  2  Association  between  chronic  obstructive  pulmonary  disease  and  smoking,  woodsmoke,  dust,  environmental  pollution
and genetic  factors.
Factor  Cases
n  =  106
Number  --  percentage
Controls
n  =  212
Number  --  percentage
OR  (95%  CI)  Value  P
Smoker
Yes  66  (62.3)  119  (56.1) 1.28
(0.80--2.07) .296No 40  (37.7)  93  (43.9)
Ex smoker
Yes  28  (26.4)  61  (28.8) 0.88
(0.52--1.50) .659No 78  (73.6)  151  (71.2)
Packs-year  index
High  risk  (>20)  25  (23.6)  7  (3.3) 9.03
(3.76--21.72) .000Low-moderate  risk  (≤20)  81  (76.4)  205  (96.7)
Exposure  to  woodsmoke
Yes  65  (61.3)  86  (40.6) 2.32
(1.44--3.74) .000No 41  (38.7)  126  (59.4)
Rate of  exposure  woodsmoke  hours/year
High risk  (>100)  41  (38.7)  13  (6.1)
9.65(4.87--19.32) .000Low  risk  (≤100)  65  (61.3)  199  (93.9)
Exposure  to  dust
Yes  71  (67)  130  (61.3) 1.28
(0.7--2) .324No 35  (33)  82  (38.7)
Environmental  pollution
Yes  19  (17.9)  45  (21.2) 0.81
(0.4--1.4) .489No 87  (82.1)  167  (78.8)
Parents with  COPD
Yes  8  (7.5)  12  (5.7) 1.36
(0.5--3.4) .514No 98  (92.5)  200  (94.3)
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CSource:  Data collection forms -- produced by the author.
bstructive  pulmonary  disease,  66  (62.3%)  were  smokers  and
0  (37.7%)  were  not.  In  the  control  group,  out  of  a total  of
12  patients,  119  (56.1%)  were  smokers.  These  data  provide
n  OR  of  1.28  (95%  CI:  0.80--2.07)  and  a  P-value  of  .296.  Out
f  106  patients  with  chronic  obstructive  pulmonary  disease,
8  (26.4%)  were  former  smokers  and  78  (73.6%)  were  not.
ut  of  212  disease-free  patients,  61  (28.8%)  were  former
mokers  and  151  (71.2%)  were  not.  This  gave  an  OR  of  0.88
95%  CI:  0.52--1.50)  and  a  P-value  of  .659.  In  the  case  group  a
otal  of  106  patients  with  chronic  obstructive  pulmonary  dis-
ase  25  (23.6%)  qualiﬁed  as  high  risk  on  the  pack-year  index
nd  81  (76.4%)  qualiﬁed  as  low-moderate  risk.  In  the  con-
rol  group,  a  total  of  212  patients,  7  (3.3%)  were  at  high  risk
n  the  pack-year  index,  and  205  (96.7%)  were  low-moderate
isk.
These  data  provided  an  OR  of  9.03  (95%  CI:  3.76--21.72)
nd  a  P-value  of  .000.  A  total  of  41  COPD  patients  (38.7%)
ere  found  to  be  high  risk  on  the  h/year  index  for  exposure
o  woodsmoke  and  65  (61.3%)  were  at  low  risk.  In  the  control
roup,  13  of  the  212  patients  (6.1%)  were  found  to  be  at  high
isk  after  we  obtained  their  hours/year  index  for  exposure
o  woodsmoke,  and  199  (93.9%)  were  low  risk.  These  data
rovided  an  OR  of  9.65;  CI:  4.87--19.32  (95%)  and  a  P-value
f  .000.  The  dust  exposure  data  give  an  OR  of  1.28;  CI:  0.7--2
6
c
j95%)  and  a P-value  of  .324,  which  is  not  a  statistically  sig-
iﬁcant  risk  factor.  Nor  was  the  exposure  to  environmental
ontamination  variable  with  an  OR  of  0.81;  CI:  0.4--1.4  (95%)
nd  a  P-value  of  .489,  nor  a  history  of  father  or  mother  with
OPD  with  an  OR  of  1.36;  CI:  0.5--3.4  (95%)  and  a  P-value  of
514.
iscussion
ur  results  show  that  the  variables  associated  with  the
resence  of  COPD  in  a  population  between  40  and  85
ears  of  age  were  smoking  and  exposure  to  woodsmoke.  In
cuador,  according  to  the  National  Institute  of  Statistics  and
ensuses,23 COPD  is  the  third  cause  of  mortality  in  Ecuador.
t  is  therefore  possible  to  intervene  and  change  this  situa-
ion  in  our  environment,  with  the  awareness  that  its  main
isk  factors  can  be  worked  on.  When  comparing  the  percent-
ge  results  with  others  conducted  worldwide,  we  found  that
OPD  occurs  in  people  aged  over  60,  with  an  average  age  of
2.  This  can  be  observed  in  most  studies  in  neighbouring
ountries,  such  as  the  Colombian  study,  PREPOCOL.6
One  of  the  most  interesting  ﬁndings  among  the  sub-
ects  in  our  sample  is  the  fact  that  the  risk  of  developing
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COPD  is  low  in  the  fourth  decade  of  life,  compared  with
later  ages.  Our  results  indicate  that  the  less  educated  the
patient,  the  greater  the  risk  of  developing  COPD.  However,
at  present  there  are  no  consistent  data  establishing  a  clear
link  between  the  risk  of  developing  COPD  and  level  of  edu-
cation,  which  could  be  a  way  of  assessing  socioeconomic
status.  Paradoxically,  the  presence  of  dust  in  the  home  and
workplace  does  not  seem  to  be  related  to  the  diagnosis
of  COPD,  which  is  consistent  with  reports  on  innocuous-
ness,  if  the  exposure  time  is  short.  However  there  is  a  bias
here,  since  this  variable  has  not  been  researched.  In  our
study,  we  show  that  family  history  as  a  risk  factor  for  the
diagnosis  of  COPD  is  not  signiﬁcant.  It  was  not  conﬁrmed
whether  being  a  smoker  or  former  smoker  was  a  major  risk
factor.
We  took  the  operational  deﬁnition  of  ‘‘smoker’’  in  the
PLATINO8 study,  and  in  our  study  we  saw  that  being  a  smoker
was  not  a  risk  factor.  The  explanation  may  be  that  the
smoking  variable  was  applied  using  non-smoker,  smoker  and
former  smoker  but  it  did  not  include  how  many  cigarettes
were  smoked  per  day.
To  associate  the  risk  of  COPD  and  number  of  cigarettes
smoked,  we  used  the  packs-year  index.  Patients  in  a  high
risk  category  (over  20,  using  the  packs-year  smoking  index)
were  statistically  signiﬁcant.  This  result  is  related  to  other
analytical  studies,  for  example,  Amigo  et  al.24 show  that
patients  with  COPD  are  heavier  smokers  than  those  with-
out  the  disease.  Heavy  smokers  are  at  4  times  greater  a
risk  of  disease  than  non-smokers.  We  also  found  an  asso-
ciation  between  COPD  and  exposure  to  woodsmoke  when
the  hours/year  ratio  was  applied,  especially  in  the  case  of
patients  in  the  high  risk  category  (more  than  100  h/year).
The  results  presented  for  both  smoking  and  exposure  to
woodsmoke  -  as  these  were  modiﬁable  risk  factors  --  are
important  for  primary  prevention.
Women  who  reside  in  and  come  from  rural  areas  have
been  exposed  to  biomass  smoke,  this  being  the  main  risk
factor.  Women  in  our  society  and,  even  more  so,  those  liv-
ing  in  rural  areas,  and  are  being  or  have  been  exposed  to
woodsmoke,  are  still  relegated  from  childhood  to  tasks  of
housework  and  food  preparation  and  have  no  opportunity  to
visit  the  doctor’s  surgery.  Worse  still,  they  are  not  able  to
have  an  early  lung  function  assessment.  Therefore,  a  clini-
cal  history  from  the  general  practitioner  who  is  working  in
their  social  services  in  a  rural  area  is  required  to  investigate
the  possible  risk  factors  of  COPD  triggers.
Women  and  children  living  in  rural  areas  are  a  vulnerable
group  as  regards  suffering  from  lung  diseases,  which  are  a
consequence  of  inhaling  toxins  from  biomass  combustion.
The  idiosyncrasy  of  our  population,  coupled  with  poverty,  is
the  main  cause  identiﬁed  in  the  use  of  biomass  as  fuel,  and
poverty  is  precisely  the  main  barrier  to  introducing  change
and  using  other  less  harmful  fuels.
Healthcare  policies  must  develop  strategies  to  prevent
pulmonary,  cardiovascular  and  other  chronic  diseases  which
are  the  consequence  of  exposure  to  these  indoor  air  pol-
lutants.  Mechanisms  must  be  sought  to  warn  people  of  the
harmful  effects  of  smoking  and  biomass  smoke  (wood  for
burning)  on  lung  health.  There  are  a  number  of  different
variables  associated  with  the  development  of  COPD  and  a
knowledge  of  these  can  help  prevent  the  onset  of  this  dis-
ease  in  this  population.  Therefore,  longitudinal  studies  are
1167
equired  to  explain  the  role  of  these  factors  in  the  develop-
ent  of  the  disease.
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